Immunic Reports Positive Interim Data from Phase 2 CALLIPER

Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis

Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis
wn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wn.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

, Week Data , First Half , Patients Shows Improvements , Biomarker Nfl , Consistent Throughout , Overall Progressive Multiple Sclerosis Population , All Subtypes , Nfl Effect , Neuroprotective Potential , Brain Volume Data ,